![ENSPRYNG 120 mg for SC Injection](/upload/2021_09_085/2021090818285718f6eaLD16.jpg)
![ENSPRYNG 120 mg for SC Injection](/upload/2021_09_085/20210908182857g1bgvlcHh5.jpg)
Indications:
ENSPRYNG is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult and adolescent over 12 years old patients who are anti-aquaporin-4 (AQP4) antibody positive.
Access the link
ENSPRYNG is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult and adolescent over 12 years old patients who are anti-aquaporin-4 (AQP4) antibody positive.